GOLDMAN SACHS ON EMAMI ; BUY | TARGET ₹625

• Strategic investments target over ₹800 Cr revenue in FY27. • Axiom Ayurveda, Brillare and digital brands drive portfolio transformation. • Skin care, hair care and healthcare support growth; hikes FY27–29 EPS estimates.

EMAMI LIMITED

← Back to feed